SLGC
Somalogic Inc
NASDAQ: SLGC · HEALTHCARE · HEALTH INFORMATION SERVICES
$9.90
+0.00% today
Updated 2026-04-30
Market cap
$396.23M
P/E ratio
—
P/S ratio
4.85x
EPS (TTM)
$-0.69
Dividend yield
—
52W range
$19 – $20
Volume
1.1M
Somalogic Inc (SLGC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Operating cash flow | $-50.54M | $-28.34M | $-36.97M | $-100.67M | $-117.25M |
| Capital expenditures | $680000.00 | $1.16M | $6.73M | $5.21M | $4.64M |
| Depreciation | — | — | — | — | — |
| Stock-based comp | $13.07M | $15.17M | $28.41M | $43.61M | $24.08M |
| Free cash flow | $-51.22M | $-29.50M | $-43.70M | $-105.88M | $-121.89M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | $275.09M | $-12.94M | — |